The Carbonic Anhydrase IX inhibitor SLC-0111 as emerging agent against the mesenchymal stem cell-derived pro-survival effects on melanoma cells-Reference-Cited by-同舟云学术

The Carbonic Anhydrase IX inhibitor SLC-0111 as emerging agent against the mesenchymal stem cell-derived pro-survival effects on melanoma cells

Published:2020-01-01 Issue:1 Volume:35 Page:1185-1193
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Peppicelli Silvia¹,Andreucci Elena¹,Ruzzolini Jessica¹,Bianchini Francesca¹,Nediani Chiara¹,Supuran Claudiu T.²^ORCID,Calorini Lido¹³

Affiliation:

1. Department of Clinical and Experimental Biomedical Sciences “Mario Serio”, Section of Experimental Pathology and Oncology, University of Florence, Florence, Italy

2. Department of NEUROFARBA, University of Florence, Florence, Italy

3. Center of Excellence for Research, Transfer and High Education, DenoTHE University of Florence, Florence, Italy

Funder

Istituto Toscano Tumori

Ente Cassa di Risparmio di Firenze

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2020.1764549

Reference52 articles.

1. The tumor microenvironment and its role in promoting tumor growth

2. Microenvironmental regulation of tumor progression and metastasis

3. The Role of Stroma in Tumor Development

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting hypoxia signaling pathways in angiogenesis;Frontiers in Physiology;2024-04-25

2. Differential carbonic anhydrase activities control EBV-induced B-cell transformation and lytic cycle reactivation;PLOS Pathogens;2024-03-26

3. Isosteviol – A new scaffold for the synthesis of carbonic anhydrase II inhibitors;Results in Chemistry;2024-01

4. Differential Carbonic Anhydrase Activities Control EBV-Induced B-Cell Transformation and Lytic Cycle Reactivation;2023-09-08

5. The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs;Cancer Letters;2023-09